Clinical trial
Headache Study to Compare Aggrenox Full Dose and Reduced Dose
NCT00274586 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00274586 |
|---|---|
| Title | Headache Study to Compare Aggrenox Full Dose and Reduced Dose |
| Official title | Tolerability of a Four Weeks Treatment With Aggrenox® Modified Release Capsules b.i.d, Compared to Reduced Dose During the First Two Weeks of Treatment in a Double-Blind, Randomized Controlled Parallel Group Comparison Trial Among Taiwanese Patients With Previous TIAs or Ischemic Stroke |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cerebrovascular Accident |
| Intervention type | Drug |
| Interventions | Aggrenox® modified release capsules, Aggrenox® modified release capsules matching placebo |
| Enrollment | 100 |
| Start date | Sep 1, 2002 |
| Primary completion | Apr 1, 2003 |
| Completion | Apr 1, 2003 |
| First posted | Jan 11, 2006 |
| Last update posted | Oct 31, 2013 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: